FirstTake on Pharma - Pharma News and Analysis Podcast

Latest Episodes:

Oral Inflammatory Drugs At Key Inflection Points Feb 12, 2021

Show notes

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the week’s most important news in pharma and biotech including the latest developments for COVID-19 vaccines and antibody therapeutics, safety concerns for the JAK inhibitor class, the potential opportunity for Bristol Myers Squibb’s Tyk-2 inhibitor in psoriasis and why the FDA has turned down a new approval for Merck & Co.’s Keytruda. They also look ahead to this weekend’s ASCO-GU meeting.

Frazier's Keytruda-shaped legacy at Merck Feb 08, 2021

Show notes

FirstWord Pharma PLUS editors Michael Flanagan and Simon King discuss the week’s most important news in pharma and biotech including Pfizer’s revenue expectations for its COVID-19 vaccine, the announcement that Ken Frazier will step down as CEO at Merck & Co. and why approval of aducanumab is so critical for Biogen.